Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis.

The Open Cardiovascular Medicine Journal Pub Date : 2014-02-07 eCollection Date: 2014-01-01 DOI:10.2174/1874192401408010006

Yoshiyuki Morishita, Eiji Kusano, Daisuke Nagata

引用次数: 1

Abstract

The renin-angiotensin-aldosterone system (RAAS) blockers have been widely used in chronic kidney disease patients undergoing hemodialysis; however, whether RAAS blockers have beneficial effects for cardiovascular disease in those patients has not been fully defined. This review focuses on the effects of RAAS blockers in chronic kidney disease undergoing hemodialysis for cardiovascular disease.

查看原文本刊更多论文

肾素-血管紧张素-醛固酮阻滞剂在慢性肾病血液透析中的临床意义。

肾素-血管紧张素-醛固酮系统(RAAS)阻滞剂已广泛应用于血液透析的慢性肾病患者;然而，RAAS阻滞剂是否对这些患者的心血管疾病有有益作用尚未完全确定。本文综述了RAAS阻滞剂在慢性肾脏病血液透析治疗心血管疾病中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Open Cardiovascular Medicine Journal

自引率

0.00%

发文量